ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient’s health—enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.
Harnessing the specificity of monoclonal antibodies, ImaginAb engineers small, highly targeted proteins known as minibodies that image important molecular targets using standard Positron Emission Tomography (PET).
Our imaging tools help physicians answer important clinical questions, improving the path of care and ultimately helping patients live longer, healthier lives.
ImaginAb would like to congratulate Dr. James P. Allison, a member of its Scientific Advisory Board, on winning the Nobel Prize in Medicine. This is a well-deserved achievement earned through immense contribution to science, medicine, and patients.